STAT

JUNE 23, 2025

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by Health and Human Services Secretary Robert F. Kennedy Jr. to be delayed, citing their lack of experience and potential bias against some vaccines. “Although the appointees to [the Advisory Committee on Immunization Practices] have scientific credentials, many do not have significant experience studying microbiology, epidemiology or immunology.

Vaccines 364

Vaccines Immunization Immunity 364

PharmaVoice

JUNE 25, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Packaging 147

Packaging Immunity Immunization Drug Development 147

PharmaVoice

JUNE 18, 2025

A new pilot program announced by FDA Commissioner Dr. Martin Makary would award vouchers that could cut drug reviews to one or two months — but only for products that meet a special criteria.

219

219

BioPharma Dive

JUNE 20, 2025

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about how gene therapies will be regulated under new FDA leadership.

124

124

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

Express Pharma

JUNE 18, 2025

NEC Corporation, in collaboration with Chugai Pharmaceutical, has conducted an experiment using artificial intelligence (AI) to predict drug combinations that may improve the effectiveness of certain cancer treatments. According to the companies, the AI system may reduce the time required to produce these predictions by approximately 50 per cent when compared to Chugai’s conventional methods.

96

96

STAT

JUNE 18, 2025

Now that Gilead Sciences has won U.S. regulatory approval for its groundbreaking HIV prevention drug , the company has another hurdle to clear — ensuring the medicine can be accessed in low-income countries where the disease remains a stubborn problem. As far as Gilead is concerned, the groundwork exists to meet that goal. Last October, the drugmaker reached voluntary licensing agreements to eventually make lenacapavir available in 120 mostly low- and lower-middle-income countries.

Drug Pricing 323

Drug Pricing 323

Pharma Times

JUNE 19, 2025

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs eXmoor and Signadori Bio enter cell therapy partnership by Emily Kimber | 19th Jun 2025 | News Signadori is advancing a platform designed to overcome the challenges of treating solid cancers eXmoor Pharma and Signadori Bio have entered into a partnership aimed at advancing a gene-modified monocyte-derive

114

114

BioPharma Dive

JUNE 18, 2025

The clearance ushers in a closely-watched launch for Gilead, which aims to show a long-acting injection can upend a market dominated by oral medicines.

115

115

NY Times

JUNE 20, 2025

Most in a small group of patients receiving a stem cell-based infusion no longer needed insulin, but the drug may not suit those with more manageable type 1 diabetes.

Diabetes 111

Diabetes 111

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

JUNE 23, 2025

WASHINGTON — Jacqueline Corrigan-Curay, the top drug regulator at the Food and Drug Administration, is retiring from the agency in July.  Corrigan-Curay, who took over as acting director of the Center for Drug Evaluation and Research in January, broke the news to staff in an email shared with STAT. She said she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering support, especially during recent challenging times.

Drug Development 306

Drug Development 306

PharmaVoice

JUNE 23, 2025

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

Diabetes 147

Diabetes Packaging Biosimilars 147

The Pharmacist

JUNE 24, 2025

Community pharmacists must be embedded in multidisciplinary palliative care teams in rural communities and have access to shared care plans and health records, a new report by Hospice UK has urged. The report, called Bringing care closer to home: Improving palliative care in remote, rural and island communities, has highlighted the critical role of community […] The post Call to embed community pharmacists in multidisciplinary palliative care teams appeared first on The Pharmacist.

85

85

Express Pharma

JUNE 24, 2025

Innovator oligonucleotide-based drugs targeting central nervous system (CNS) disorders have seen a remarkable 339 per cent increase in licensing agreement deal value, rising from $640 million in 2023 to $2.81 billion in 2024, according to GlobalData. Oligonucleotides, which are short synthetic DNA or RNA strands, are utilised in precision medicine to selectively bind to disease-causing genetic sequences, offering targeted therapeutic options for complex diseases.

Pharmaceutical Companies 89

Pharmaceutical Companies Pharmaceutical Companies 89

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

BioPharma Dive

JUNE 20, 2025

Prothena will cut 63% of its workforce and evaluate a “range of business options.” Elsewhere, Zealand revealed data for a dual-acting obesity drug and Biogen kicked off a new late-stage trial.

109

109

STAT

JUNE 20, 2025

Twelve people with type 1 diabetes who received an investigational off-the-shelf stem cell therapy were able to produce their own insulin and keep healthy blood glucose levels for at least one year, Vertex Pharmaceuticals said Friday. After three months, none of them suffered severe bouts of low blood sugar. After 12 months, out of the 12 participants, 10 no longer needed to inject insulin.

Diabetes 362

Diabetes 362

PharmaVoice

JUNE 24, 2025

J&J’s former head of R&D, now CEO of Parabilis Medicines, aims to remain above the biotech fray by taking on unique targets from which others have steered clear.

130

130

Pharma Times

JUNE 24, 2025

Enter this year's famous competition

110

110

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

NY Times

JUNE 21, 2025

Aid cuts have reached a level where they undermine our national interest as well as corrode our souls.

Immunization 109

Immunization Immunity 109

BioPharma Dive

JUNE 23, 2025

The Wegovy maker says the telehealth company didn't stop selling compounded versions of the blockbuster drug after Novo resolved its shortage.

Compounding 95

Compounding 95

STAT

JUNE 23, 2025

Novo Nordisk is ending a deal with telehealth company Hims & Hers, saying Monday that Hims has been engaging in “illegal mass compounding” of GLP-1 obesity treatments and “deceptive marketing.” Earlier this year, Novo launched a direct-to-consumer website that sells its obesity drug Wegovy at a lower price to patients who are paying on their own without insurance.

Compounding 254

Compounding 254

Drug Channels

JUNE 18, 2025

This week, I’m rerunning some popular posts while I prepare for Friday’s live video webinar: What’s Next for Retail Pharmacy: Data, Debate, and Disruption. I’ll be joined by special guest Antonio Ciaccia, CEO of 46brooklyn Research, and President of 3 Axis Advisors. Click here to see the original post from April 2025. Drug Channels Institute’s (DCI’s) latest analysis reveals that PBM-affiliated specialty pharmacies continue to dominate the dispensing of specialty drugs.

Specialty Pharmacies 75

Specialty Pharmacies 75

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

The Pharmacist

JUNE 19, 2025

New medicines can transform the treatment and prevention of disease, improving – and in many cases saving – lives. But no health system has unlimited resources. This creates a political and technical challenge for governments and health systems which must decide which drugs to make available and to whom. Few areas of health policy are […] The post How new medicines become available on the NHS appeared first on The Pharmacist.

92

92

Express Pharma

JUNE 23, 2025

Glenmark Pharmaceuticals, has announced the launch of TEVIMBRA (tislelizumab) in India after receiving regulatory approval from the Central Drugs Standard Control Organisation (CDSCO). This marks Glenmark’s entry into the field of immune-oncology within the country. TEVIMBRA is an anti-PD-1 monoclonal antibody originally developed by BeiGene, which now operates as BeOne Medicines.

Immunization 91

Immunization Immunity Chemotherapy 91

BioPharma Dive

JUNE 18, 2025

A new pilot program announced by FDA Commissioner Martin Makary would award vouchers that could cut drug reviews to one or two months — but only for products that meet a special criteria.

87

87

STAT

JUNE 20, 2025

As former chairs of the CDC’s Advisory Committee on Immunization Practices ( ACIP ), we are deeply alarmed by the growing politicization of vaccines — a public health innovation that has saved 154 million lives globally. While politicization of science is not new, the escalating distrust in science across the political spectrum, and its intrusion into the vaccine ecosystem, now threatens the very infrastructure that has long protected Americans from infectious diseases.

Immunization 363

Immunization Immunity Vaccines 363

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.